Drug maker Lupin today said its three of its 100 per cent subsidiaries, including Lupin Pharmacare, would merge with the parent company.
Lupin Pharmacare and Lupin Herbal, two wholly-owned subsidiaries of Lupin, have filed applications before the Bombay High Court, to amalgamate themselves with the company, the pharmaceuticals firm said in a filing to the Bombay Stock Exchange (BSE).
Further, another subsidiary of the company Novodigm will shortly be filing an application before the Ahmedabad High Court to amalgamate itself with Lupin, it said.
The appointed date of merger of these three firms is April 1, it added.
Shares of Lupin were trading at Rs 1145, up 2.16 per cent in the afternoon trade on the BSE.
